|
|
||||||||
CUTTING EDGE |


,
,¶
* Ottawa Regional Cancer Center,
Department of Biochemistry, Microbiology and Immunology, University of Ottawa,
Ottawa Hospital Research Institute,
Division of Rheumatology, Department of Medicine, University of Ottawa,
¶ Novasante Corp., Ottawa, Canada
Nitrotyrosine is widely recognized as a surrogate marker of up-regulated inducible NO synthase expression at sites of inflammation. However, the potential immunogenicity of autologous proteins containing nitrotyrosine has not previously been investigated. Herein, we used the I-EK-restricted T cell epitope of pigeon/moth cytochrome c (PCC/MCC88103) to assess the ability of T cells to recognize ligands containing nitrotyrosine. Substitution of the single tyrosine (Y97) in PCC/MCC88103 with nitrotyrosine abrogates recognition by the MCC88103-specific T cell hybridoma 2B4. CBA (H2K) mice immunized with MCC88103 or nitrated MCC88103 peptides produce T cell responses that are mutually exclusive. Transgenic mice that constitutively express PCC under the control of an MHC class I promoter are tolerant toward immunization with MCC88103, but exhibited a robust immune response against nitrated MCC88103. Analysis of T cell hybridomas specific for nitrated-MCC88103 indicated that subtle differences in TCR VDJ gene usage are sufficient to allow nitrotyrosine-specific T cells to escape the processes of central tolerance.
This article has been cited by other articles:
![]() |
L. L. Hardy, D. A. Wick, and J. R. Webb Conversion of Tyrosine to the Inflammation-Associated Analog 3'-Nitrotyrosine at Either TCR- or MHC-Contact Positions Can Profoundly Affect Recognition of the MHC Class I-Restricted Epitope of Lymphocytic Choriomeningitis Virus Glycoprotein 33 by CD8 T Cells J. Immunol., May 1, 2008; 180(9): 5956 - 5962. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimizu, Y. Osaka, C. Banri-Koike, M. Yoshida, K. Endo, K. Furukawa, M. Oda, A. Murakami, S. Ogawa, R. Abe, et al. T cells specific to hapten carrier but not to carrier alone assist in the production of anti-hapten and anti-carrier antibodies Int. Immunol., October 1, 2007; 19(10): 1157 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Parastatidis, L. Thomson, D. M. Fries, R. E. Moore, J. Tohyama, X. Fu, S. L. Hazen, H. F.G. Heijnen, M. K. Dennehy, D. C. Liebler, et al. Increased Protein Nitration Burden in the Atherosclerotic Lesions and Plasma of Apolipoprotein A-I Deficient Mice Circ. Res., August 17, 2007; 101(4): 368 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Thomson, J. Christie, C. Vadseth, P. N. Lanken, X. Fu, S. L. Hazen, and H. Ischiropoulos Identification of Immunoglobulins that Recognize 3-Nitrotyrosine in Patients with Acute Lung Injury after Major Trauma Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 152 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ireland, J. Herzog, and E. R. Unanue Cutting Edge: Unique T Cells That Recognize Citrullinated Peptides Are a Feature of Protein Immunization J. Immunol., August 1, 2006; 177(3): 1421 - 1425. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Mathews, W. L. Suarez-Pinzon, J. J. Baust, K. Strynadka, E. H. Leiter, and A. Rabinovitch Mechanisms Underlying Resistance of Pancreatic Islets from ALR/Lt Mice to Cytokine-Induced Destruction J. Immunol., July 15, 2005; 175(2): 1248 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Herzog, Y. Maekawa, T. P. Cirrito, B. S. Illian, and E. R. Unanue Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells PNAS, May 31, 2005; 102(22): 7928 - 7933. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Gow, C. R. Farkouh, D. A. Munson, M. A. Posencheg, and H. Ischiropoulos Biological significance of nitric oxide-mediated protein modifications Am J Physiol Lung Cell Mol Physiol, August 1, 2004; 287(2): L262 - L268. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |